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O B J E C T I V E S The purpose of this study was to assess the prognostic value of global magnetic
resonance (MR) myocardial perfusion imaging (MPI) in women with suspected myocardial ischemia and
no obstructive (stenosis 50%) coronary artery disease (CAD).
B A C KG ROUND The prognostic value of global MR-MPI in women without obstructive CAD
remains unknown.
METHOD S Women (n  100, mean age 57  11 years, age range 31 to 76 years), with symptoms
of myocardial ischemia and with no obstructive CAD, as assessed by coronary angiography, underwent
MR-MPI and standard functional assessment. During follow-up (34  16 months), time to ﬁrst adverse
event (death, myocardial infarction, or hospitalization for worsening anginal symptoms) was analyzed
using global MPI and left ventricular ejection fraction (EF) data.
R E S U L T S Adverse events occurred in 23 (23%) women. Using univariable Cox proportional hazards
regression modeling, variables found to be predictive of adverse events were global MR-MPI average
uptake slope (p  0.05), the ratio of MR-MPI peak signal amplitude to uptake slope (p  0.05), and EF
(p  0.05). Two multivariable Cox models were formed, 1 using variables that were performance site
dependent: ratio of MR-MPI peak amplitude to uptake slope together with EF (chi square: 13, p 0.005);
and a model using variables that were performance site independent: MR-MPI slope and EF (chi square:
12, p  0.005). Each of the 2 multivariable models remained predictive of adverse events after
adjustment for age, disease history, and Framingham risk score. For each of the Cox models, patients
were categorized as high risk if they were in the upper quartile of the model and as not high risk
otherwise. Kaplan-Meier analysis of time to event was performed for high risk versus not high risk for
site-dependent (log rank: 15.2, p  0.001) and site-independent (log rank: 13.0, p  001) models.
CONC L U S I O N S Among women with suspected myocardial ischemia and no obstructive CAD,
MR-MPI–determined global measurements of normalized uptake slope and peak signal uptake, together
with global functional assessment of EF, appear to predict prognosis. (J Am Coll Cardiol Img 2010;3:
1030–6) © 2010 by the American College of Cardiology Foundation
I
(
(
i
(
p
r
p
e
s
a
n
w
o
o
I
l
e
m
t
i
m
a
o
d
t
r
m
m
C
o
h
p
g
M
S
b
w
t
B
d
t
w
f
M
s
s
(
O
w
s
f
I
B
o
t
b
d
e
t
s
o
t
fi
l
R
M
a
s
e
I
o
m
B
t
P
c
o
s
t
t
F
t
‡
D
A
h
P
R
A
T
a
6
U
L
M
v
S
B
a
W
M
2
magnetic resonance
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 3 , N O . 1 0 , 2 0 1 0
O C T O B E R 2 0 1 0 : 1 0 3 0 – 6
Doyle et al.
Global MR Perfusion in Women
1031n the U.S., cardiovascular disease is the leading
cause of mortality in women (1). However, women
are less likely than men to have either classic
symptoms or obstructive coronary artery disease
CAD), but paradoxically have a worse prognosis
2,3). This may be an expression of the failure to
dentify factors contributing to a woman’s risk
4–6). Conventional noninvasive testing in this
opulation is particularly challenging due to the
elatively low prevalence of obstructive CAD, cou-
led with the observations that first cardiovascular
vents are often fatal in women (7), and that
tenoses 70% are associated with the majority of
cute ischemic cardiac events (8). Thus, there is a
eed to develop risk assessment approaches for
omen to better assess risk of adverse events as
pposed to being at high risk for significant or
bstructive CAD (9). The WISE (Women’s
schemia Syndrome Evaluation) study has estab-
ished that women who are symptomatic of isch-
mia but without obstructive CAD experience
ore adverse events than nonsymptomatic con-
rols (10).
Magnetic resonance (MR) myocardial perfusion
maging (MPI) is an evolving high-resolution to-
ographic modality with no ionizing radiation that
llows detection of regional hypoperfusion. We and
thers have reported that obstructive CAD can be
etected with a sensitivity and specificity comparable
o conventional radionuclide imaging (11,12). A prior
eport suggested that MR-MPI can detect nonseg-
ental, subendocardial abnormalities suggestive of
yocardial ischemia in patients without obstructive
AD (13); however, the relationship between this
bservation and risk has not been evaluated. We
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010, accepted July 13, 2010.ypothesized that in a cohort of women with sus-
ected ischemia but no obstructive epicardial CAD,
lobal MR-MPI measures may predict prognosis.
E T H O D S
tudy population. Symptomatic women with sta-
le angina and suspected myocardial ischemia
ere prospectively enrolled in the National Insti-
utes of Health–National Heart, Lung, and
lood Institute–sponsored WISE study and un-
erwent quantitative coronary angiography. From
his enrolled population, 100 consecutive women
ith coronary artery stenoses 50% were selected
or this substudy and underwent first-pass contrast
R-MPI within 1 week of enrollment. This pro-
pective substudy was performed at a single WISE
ite, the University of Alabama at Birmingham
UAB), between the dates of November 1993 and
ctober 1998, and included WISE participants
ith no contraindications for MR examination. All
ubjects provided informed consent using
orms and procedures approved by the
nstitutional Review Board at UAB.
aseline evaluation. The WISE methodol-
gy for acquisition of MR-MPI and quan-
itative coronary angiography data has
een described previously (14,15). In brief,
emographic data, risk factors for isch-
mic heart disease, medical and reproduc-
ive history, functional capacity, and blood
amples were acquired and evaluated. Cor-
nary artery status was assessed qualita-
ively and quantitatively using cine angiographic
lms evaluated at the WISE angiographic core
aboratory (Rhode Island Hospital, Providence,
hode Island) (15).
R-MPI acquisition. MR first-pass MPI data were
cquired using an optimized Philips ACS 1.5-T
canner (Philips Medical Systems, Best, the Neth-
rlands) using previously described methods (12).
n brief, imaging was performed in the short-axis
rientation during the passage of a bolus (0.1
m/kg) of gadolinium contrast agent (ProHance,
erlex, Montville, New Jersey) using a power injec-
or (Spectris MR Injection System, Medrad Inc.,
ittsburgh, Pennsylvania). Imaging parameters in-
luded a field of view of 250 to 450 mm (depending
n patient dimensions) and 2 slices imaged with
lice-selective saturation pulse applied 150 ms prior
o imaging using a keyhole approach (repetition
ime/echo time/flip: 7/3.5/20°) to sample 32 lines of
A B B
A N D
CAD
EF e
LV
MI
MPI
imagi
MR-space inserted into a 1282 matrix. DataR E V I A T I O N S
A C R O N YM S
coronary artery disease
jection fraction
left ventricle/ventricular
myocardial infarction
myocardial perfusion
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1032cquired for each heartbeat, and signal reception
as accomplished using a body coil. Stress hyper-
mia was induced by intravenous administration of
ipyridamole (0.14 mg/kg/min or 0.56 mg/kg over
min). To maximize the hyperemic response,
atients were instructed to abstain from foods
ontaining methylxanthine (e.g., caffeine and theo-
romine), such as coffee, tea, and chocolate, and
rom use of medications containing nitrates for at
east 12 h prior to the study. Myocardial perfusion
tatus was analyzed at rest and under stress hyper-
mic conditions to extract myocardial perfusion
ariables.
R-MPI analysis. Global MPI indices, including av-
rage uptake slope and peak signal amplitude, were
easured in the time-resolved MR data using
ustom-designed software developed at UAB (Fig. 1).
o compensate for respiratory motion, each image
rame was displaced such that the left ventricle (LV)
Figure 1. MR-MPI Analysis for Low Average and High Average M
The top panel shows a patient with a low average myocardial perf
high average MPI level. Six myocardial regions and a left ventricula
and parameterized intensity–time curves are shown in the right-ha
and each of 6 myocardial sections (closely grouped uptake curves
present, whereas the patient with low MPI subsequently died and t
resonance.as registered over the time series. The uptake
lopes were low-pass filtered to remove noise (body-
oil reception resulted in relatively high noise lev-
ls). Perfusion variables were extracted from 6
anually drawn, circumferentially defined regions
n each of 2 short-axis slices covering the mid- and
pical LV sections. Intensity–time curves for each
yocardial region were extracted by semiautomat-
cally identifying the inflection point of signal
ncrease and the peak signal amplitude achieved
uring the first pass. Using the uptake data between
hese 2 points, a linear line was curve fitted, and the
lope of signal intensity per unit time was extracted.
he uptake slope for each myocardial region was
ormalized by dividing by the slope of the LV
lood pool signal (the dominant curve seen in
ig. 1) and the normalized value scaled by multi-
lication by 1,000 to make the values comparable to
verage peak signal intensity (arbitrary units). The
Levels
n image (MPI) level and the lower panel shows a patient with a
od pool region are drawn on 1 frame (lower inset). Extracted
isplay section for the left ventricular blood pool (highest peak)
these patients, no perfusion defects or obstructive stenoses were
atient with high MPI survived event free. MR  magneticPI
usio
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1033eak signal intensity was calculated as the difference
etween the mean baseline signal prior to contrast
rrival and the peak signal intensity. Each parame-
er was evaluated separately at rest and at stress. All
erfusion data were obtained and recorded prior to
nmasking clinical and follow-up results.
R cardiac function acquisition. During the MPI
can, short-axis cine views were acquired using a
radient-recalled echo (repetition time/echo time/
ip: 7/4/30) in multiple contiguous slices covering
he base to the apex and oriented parallel to the
ase. The endocardial boundaries were planime-
ered using a commercial analysis package (Medis,
eiden, the Netherlands) to extract end-diastolic
nd -systolic volumes, and the ejection fraction
EF) was calculated.
ollow-up procedures. For follow-up, a scripted
elephone interview was performed by experienced
esearch coordinators at 6 weeks after enrollment
nd yearly thereafter. The events of interest in-
luded all-cause mortality, first incidence of myo-
ardial infarction (MI), or hospitalization for wors-
ning anginal symptoms. Median follow-up was
4  16 months. In the event of death, a death
ertificate and/or hospital record was obtained
hen available.
tatistical analysis. Continuous values were pre-
ented as mean  SD and categorical variables as
ercent frequency. Continuous clinical and demo-
raphic characteristics were compared between
roups using the independent samples t test; the
hi-square test was used for categorical compari-
ons. The predictors of adverse events (death, MI,
ospitalization for worsening angina) were identi-
ed by univariable Cox regression analyses. Two
ultivariable Cox proportional hazard regression
Cox) models were formed for variables shown to be
redictive in univariable analysis at the level of p 
.05: 1 model incorporating performance site–
ependent variables, and 1 model incorporating
erformance site–independent variables. Patients in
he upper quartile of each of the 2 multivariable
ox models were designated high risk, with not
igh-risk status assigned to all others. The propor-
ional hazards assumption of invariant hazard ratios
as found to be met for the high-risk and not
igh-risk predictors in the model. Kaplan-Meier anal-
sis was performed to assess the effect of risk stratifi-
ation on survival and was tested using the log-rank
tatistic. All p values are 2 tailed. A p value0.05 was
onsidered statistically significant. Statistical analyses
ere performed using SPSS version 14.0 (SPSS Inc.,
hicago, Illinois).E S U L T S
opulation characteristics. The mean age was 57 
1 years (range 31 to 76 years); 30% were ethnic
inorities, primarily African Americans, and the
verage maximal stenosis level was 19  19%
median 22.0, range 0% to 49%). Demographic data
re summarized in Table 1. Adverse events occurred
n 23 women (23%), consisting of 19 hospitaliza-
ions for worsening anginal symptoms, 2 deaths,
nd 2 MIs. All deaths were deemed cardiovascular
nd were confirmed by the National Death Index.
lso shown in Table 1 are the demographic values
or event and event-free groups.
ite-dependent MR-MPI and cardiac function predictors
f adverse events. Imaging variables predictive of
vents by univariable Cox regression modeling
ere: the global MR-MPI ratio of average peak
ignal to normalized uptake slope at stress (p 
.05) and EF (p  0.05) (Table 2). Since the peak
ignal amplitude is measured in arbitrary units, it is
Table 1. Population Characteristics of Women
Variable
Total
(n  100)
Event-Fre
(n  77
Black or Hispanic 30 30
Age, yrs 57 11 57 10
Hypertension 66 63
Dyslipidemia 50 49
History of smoking 47 43
Obesity (body mass index 30 kg/m2) 42 39
Diabetes mellitus 20 19
Typical angina presentation 34 41*
Family history of premature CAD 76 75
Coronary artery stenosis, % 19 19 18 19
Left ventricular ejection fraction, % 62 9 64 7*
Left ventricular ejection fraction 55% 15 12
Resting heart rate, beats/min 68 13 67 12
Hyperemic heart rate, beats/min 84 13 83 12
Systolic blood pressure, mm Hg 137 22 137 22
Diastolic blood pressure, mm Hg 75 11 75 11
ATP III 10-year risk of MI 4.5 4.2 4.4 4.4
Values are % or mean  SD. *p  0.05 between event-free and adverse event
ATP  Adult Treatment Panel; CAD  coronary artery disease; MI  myocard
Table 2. Cox Model Parameters
Predictor
Hazard
Ratio
95%
Lower CI
95%
Upper CI
EF 0.949 0.911 0.990
Amp/slope  1,000 0.516 0.314 0.848
Slope  1,000 1.005 1.001 1.009e
)
Adverse Event
(n  23)
30
58 12
74
73
61
52
22
13*
78
21 21
59 12*
26
71 16
85 14
138 22
76 10
4.9 3.9
groups.Amp  amplitude; CI  conﬁdence interval; EF  ejection fraction.
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1034performance site–dependent variable. Using the
orward selection method, the variables EF and the
atio of average peak signal to normalized uptake
lope were entered to form a multivariable Cox
odel (chi-square: 13.2, p  0.001). The multiva-
iable Cox model was divided into quartiles, and
hose in the highest-risk quartile were categorized
s high risk, with all others categorized as not high
Follow-Up Time (Months)
0 8 17 25 33 42
High-Risk
Not High-Risk
aplan-Meier Survival Stratiﬁed by MR-MPI and Cardiac
isk Measures
ier cumulative event-free survival curves for adverse events (p 
igh-risk and not high-risk patients stratiﬁed by highest quartile of
incorporating the ratio of MR-MPI average amplitude to normal-
haracteristics of Women in High-Risk Versus Not
riable
Not High-Risk
(n  75)
High-Risk
(n  25)
25 44
58 11 55 11
67 64
53 60
40* 68*
dex 30 kg/m2) 36* 60*
17 28
ation 36 28
ature CAD 75 79
is, % 19 20 20 20
n fraction, % 65 7† 57 102†
n fraction 55% 9† 32†
ts/min 66 12* 72 16*
beats/min 82 13* 90 13*
, mm Hg 135 21 144 25
e, mm Hg 73 11* 79 8*
I 4.7 4.5 3.8 3.4
D. *p  0.05 and †p  0.001 between not high-risk and high-risk groups.
1.o
slope and ejection fraction. Abbreviations as in Figure 1.isk. Table 3 compares demographic values between
igh-risk and not high-risk patients. Kaplan-Meier
urvival curves indicated that there was a significant
ifference in time to adverse event between risk
roups (log-rank: 15.0, p  0.001) (Fig. 2). Annu-
lized event rates were 12% for those in the high-
isk group compared with 4% for patients in the not
igh-risk group. In the high-risk group, there were
deaths and 10 hospitalizations for worsening
ngina, whereas in the low-risk group, there were 2
Is and 9 hospitalizations for worsening angina.
ite-independent MR-MPI and cardiac function predictors
f adverse events. Since the MR-MPI variable of
ormalized uptake slope is a ratio, it can be mea-
ured in a site-independent manner. The normal-
zed uptake slope at stress was entered into a
nivariable Cox model and was predictive of events
p  0.05) (Table 2). We formed a multivariable
ox regression model by conditionally entering the
ormalized uptake slope and EF (chi-square: 12.0,
 0.001). The multivariable Cox model was
ivided into quartiles, and those in the highest
uartile were categorized as high risk, with all
thers categorized as not high risk. Kaplan-Meier
urvival analysis showed significant difference in
ime to adverse event between the high-risk group
ersus the not high-risk group (log-rank: 13.0, p 
.001). Annualized event rates were 12% for those
n the high-risk group compared with 4% for those
n the not high-risk group.
I S C U S S I O N
urs is the first study, to our knowledge, to show
hat global MR-MPI variables are predictive of
dverse events among women with suspected isch-
mia but no obstructive CAD. This is an important
bservation, given the controversy in the current
iterature concerning the existence of MR-MPI–
etected perfusion defects in similar populations of
atients. One recent study demonstrated a strong
orrelation between perfusion defects by MR-MPI
nd impaired coronary microvascular function (16),
hereas another study failed to demonstrate these
orrelations (17). In a recent editorial, Pennell
ddressed the divergent opinions by noting the
mportance of correctly categorizing patient popu-
ations (18). The current study represents a well-
tudied and categorized population of women with
ymptoms of ischemia and objective evidence of noCu
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1035n core laboratories and using standardized collec-
ion and data analyses methods.
We showed that when considering MPI param-
ters at stress, averaged over all regions, possessing
low uptake signal with a steep normalized uptake
lope was associated with increased events (i.e., a
harp uptake of perfusion, but reaching only a low
evel). These conditions correspond to low perfu-
ion levels, possibly representative of abnormal sub-
ndocardial perfusion secondary to microvascular
oronary dysfunction (19). These globally low per-
usion conditions would normally not be detected
y standard comparative analyses aimed at identi-
ying segmental perfusion abnormalities. Thus,
hen using the MPI data to evaluate patients
ith suspected ischemia, 2 separate analyses
hould be performed, 1 to detect low perfusion
egions consistent with obstructive CAD and 1 to
etect globally low myocardial perfusion condi-
ions that are independently associated with ad-
erse events.
In addition to globally low perfusion conditions,
he highest-risk patients had a low EF value. From
able 3, it is apparent that high-risk patients
ended to be obese, with a history of smoking, and
ad higher resting and stress heart rates. High-risk
atients were those with MPI and EF parameters
onsistent with the presence of microvascular
oronary dysfunction. Importantly, a comprehen-
ive evaluation of regional and global perfusion
onditions, along with functional status, can be
erformed noninvasively during a single MPI
xamination.
Pathophysiologic mechanisms to explain the rel-
tively high prevalence of adverse events associated
ith abnormal global MR-MPI measures and poor
ardiac function include primary myocyte and/or
icrovascular coronary dysfunction, even in the
bsence of obstructive CAD. Other WISE data
uggest that patients with symptoms of ischemia
ut no obstructive CAD likely have microvascular
oronary dysfunction (20), which is associated with
n adverse prognosis (21,22). More work is needed
o characterize both the pathophysiology and non-
nvasive diagnostic tools such as global MR-MPI.
Current diagnostic modalities used to detect
yocardial ischemia include radionuclide perfusion
nd echocardiography imaging. The diagnostic ac-
uracy of these tests in women is limited by the
ptimization of these techniques for the detection
f segmental abnormalities most correlative to ob-
tructive CAD, as well as the confounding effects in tadionuclide imaging tissue attenuation (23). Car-
iac MR imaging has excellent soft tissue charac-
erization and contrast, 3-dimensionality, and over-
ll good temporal and spatial resolution. Prior
tudies document its utility for detection of seg-
ental perfusion defects (12), and the current
esults suggest that cardiac MR may uniquely be
ositioned to detect global perfusion abnormalities
hat are of prognostic significance.
linical relevance. Women with signs and symp-
oms suggestive of myocardial ischemia but no
bstructive CAD present a major challenge because
urrent management is largely based on the degree
f obstructive CAD visualized by traditional coro-
ary angiography. Recent studies demonstrate that
here is a sizable subset of patients, often female,
ith evidence of ischemia but no obstructive CAD
ho have an adverse prognosis. We showed that
lobal, nontraditional myocardial perfusion vari-
bles predicted events. Further validation of these
esults, with application in patients with suspected
schemia but no obstructive CAD, could enhance
iagnosis and prognosis abilities over current
odalities.
tudy limitations. The sample size and number of
vents are relatively small, and current results are
nderpowered to detect the relationship between
pecific MR-MPI measures and serious adverse
vents. Due to the small sample size and low
umber of events, it was not feasible to consider
ovariates in the Cox models. Improvements in
R-MPI resolution and extent of myocardium
overed have occurred since these data were col-
ected that now allow analyses to be performed
eparately for endocardial, mid-, and epicardial
ayers, and should provide improved evaluation and
nderstanding of myocardial perfusion. The rela-
ively low resolution of our perfusion images in the
urrent study precluded performing separate analy-
es for subendocardial versus other myocardial lay-
rs. No late gadolinium enhancement was per-
ormed to detect nonviable myocardium. Since a
ody coil was used for acquisition, perfusion uptake
ignal required filtering to remove excessive noise.
ut points for not high-risk versus high-risk pa-
ients for adverse events by global MR-MPI and
unctional variables were defined using clinical out-
omes data for adverse events. This methodology
as then used to retrospectively predict outcome
nd is likely to overestimate the strength of the
odel. Even lesions 50% could progress duringhe follow-up time and explain these events.
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1036O N C L U S I O N S
mong women with suspected ischemia but no
bstructive CAD, global MR-MPI perfusion ab-
ormalities predict adverse events. These data add
o the literature and suggest that global MR-MPI8. Fishbein MC, Siegel RJ. How big
are coronary atherosclerotic plaques nary microvasculaial ischemia, possibly secondary to microvascular
oronary dysfunction.
eprint requests and correspondence: Dr. Mark Doyle,
ivision of Cardiology, CV MRI Center, Allegheny
eneral Hospital, 320 East North Avenue, Pittsburgh,abnormalities may be indicative of global myocar- Pennsylvania 15212-4772. E-mail: mdoyle@wpahs.org.1
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